News XOMA Corporation Nasdaq

Equities

XOMAO

US98419J4040

Market Closed - Nasdaq Other stock markets 21:30:01 14/06/2024 BST			5-day change	1st Jan Change
25.16 ^USD	-0.73%		+0.25%	+0.17%

06-12	XOMA Receives $8.1 Million Milestone Related to Sale of Priority Review Voucher	MT
05-09	Earnings Flash (XOMA) XOMA CORPORATION Reports Q1 Revenue $1.5M	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals Sale of its Priority Review Voucher	06-13	AQ
XOMA Receives $8.1 Million Milestone Related to Sale of Priority Review Voucher	06-12	MT
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher	06-12	AQ
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ	05-14	AQ
Earnings Flash (XOMA) XOMA CORPORATION Reports Q1 Revenue $1.5M	05-09	MT
Xoma: Q1 Earnings Snapshot	05-09	AQ
XOMA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities	05-09	AQ
XOMA : 2024 Letter to Shareholders	05-09	PU
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%	04-30	AQ
XOMA Corporation completed the acquisition of three First-in-Category Assets of Daré Bioscience, Inc. for $22 million.	04-29	CI
Leerink Partners Starts XOMA With Outperform Rating, $40 Price Target	04-29	MT
XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)	04-25	AQ
XOMA : Acquisition/Asset Disposal - Form 8-K	04-03	PU
XOMA Corporation Announces Closing of Tender Offer	04-03	AQ
XOMA Corporation completed the acquisition of Kinnate Biopharma Inc..	04-02	CI
XOMA Declares Quarterly Preferred Stock Dividends	03-21	AQ
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.	03-19	AQ
Xoma: Q4 Earnings Snapshot	03-08	AQ
XOMA Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News XOMA Corporation Nasdaq

Equities

XOMAO

US98419J4040

Summary

Filters